Skip to main content
Loading navigation...
Mysimba 8mg/90mg Prolonged-Release Tablets – 112 Tablets

Mysimba 8mg/90mg Prolonged-Release Tablets – 112 Tablets

Pack size: 112 prolonged-release tablets

Manufacturer: Orexigen Therapeutics Ireland Limited

£105.00

Prescription required

Mysimba is a prescription-only medicine containing naltrexone hydrochloride and bupropion hydrochloride.

It is licensed for weight management in adults with an initial BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition, alongside a reduced-calorie diet and increased physical activity.

Treatment is subject to an individual clinical assessment by an authorised prescriber. Continued treatment requires monitoring of effectiveness, safety and tolerability.

Each prolonged-release tablet contains naltrexone hydrochloride 8mg and bupropion hydrochloride 90mg.

Other ingredients include lactose, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate and other excipients detailed in the patient information leaflet.

WhatsApp